Jason C Hsu

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Cerebrospinal Fluid

Coronavirus Disease

Health Insurance

Epidermal Growth Factor Receptor

Top Venues

Clinical drug investigation

Journal of bone and mineral metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Tzu-Hsuan Tseng, Shao-Chin Chiang, Jason C Hsu, Yu Ko
Cost-effectiveness analysis of granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced febrile neutropenia in patients with breast cancer in Taiwan. PloS one 19 (6) (2024)
Tzu-Hsuan Tseng, Shao-Chin Chiang, Jason C Hsu, Yu Ko
Cost-effectiveness analysis of granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced febrile neutropenia in patients with breast cancer in Taiwan. PloS one 19 (6) (2024)
Hsiao-Ya Peng, Yen-Kuang Lin, Phung-Anh Nguyen, Jason C Hsu, Chun-Liang Chou, Chih-Cheng Chang, Chia-Chi Lin, Carlos Lam, Chang-I Chen, Kai-Hsun Wang, Christine Y Lu
Determinants of coronavirus disease 2019 infection by artificial intelligence technology: A study of 28 countries. PloS one 17 (8) (2022)
Jason C Hsu, Chen-Fang Wei, Szu-Chun Yang, Peng-Chan Lin, Yang-Cheng Lee, Christine Y Lu
Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: an interrupted time series study. BMJ open 10 (5) (2020)
Jason C Hsu, Jia-Yu Lin, Peng-Chan Lin, Yang-Cheng Lee
Comprehensive value assessment of drugs using a multi-criteria decision analysis: An example of targeted therapies for metastatic colorectal cancer treatment. PloS one 14 (12) (2019)
Jason C Hsu, Chen-Fang Wei, Szu-Chun Yang
Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: an interrupted time series study. BMJ open 9 (3) (2019)
Hsiang-Yin Chen, Pei-Yin Chiu, Ching-Jun Chang, Lih-Ling Tsai, Ya-Lan Huang, Jason C Hsu
Replacement Effects and Budget Impacts of Insurance Coverage for Sodium-Glucose Co-Transporter-2 Inhibitors on Oral Antidiabetic Drug Utilization. Clinical drug investigation 38 (12) (2019)
Kun-Ling Wu, Chih-Hsing Wu, Yin-Fan Chang, Yun-Ting Lin, Jason C Hsu
Budget impact analysis of osteoporosis medications for primary prevention of fractures in Taiwan. Journal of bone and mineral metabolism 38 (3) (2019)
Jason C Hsu, Yu-Chi Su, Bo-Yun Tang, Christine Y Lu
Use of assisted reproductive technologies before and after the Artificial Reproduction Act in Taiwan. PloS one 13 (11) (2018)
Jason C Hsu, Huai-Chueh Wu, Wen-Chia Feng, Chih-Ho Chou, Edward Chia-Cheng Lai, Christine Y Lu
Disease and economic burden for rare diseases in Taiwan: A longitudinal study using Taiwan's National Health Insurance Research Database. PloS one 13 (9) (2018)
Jason C Hsu, Jia-Yu Lin, May-Ying Hsu, Peng-Chan Lin
Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan. PloS one 13 (8) (2018)